Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VAV2 mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | VAV2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VAV2 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | increases expression | ISO | Vav2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of VAV2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | ISO | VAV2 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of VAV2 mRNA | CTD | PMID:30165855 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Vav2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VAV2 mRNA | CTD | PMID:33387578 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of VAV2 mRNA | CTD | PMID:21346803 | 2-butoxyethanol | decreases expression | ISO | Vav2 (Mus musculus) | 6480464 | n-butoxyethanol results in decreased expression of VAV2 mRNA | CTD | PMID:19812364 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Vav2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of VAV2 mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Vav2 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of VAV2 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | VAV2 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of VAV2 gene | CTD | PMID:31601247 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Vav2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of VAV2 mRNA | CTD | PMID:16467112 | acetohydrazide | decreases expression | ISO | Vav2 (Mus musculus) | 6480464 | acetylhydrazine results in decreased expression of VAV2 mRNA | CTD | PMID:15282401 | aflatoxin B1 | increases expression | ISO | Vav2 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of VAV2 mRNA | CTD | PMID:19770486 | aflatoxin B1 | affects methylation | ISO | VAV2 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the methylation of VAV2 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | affects methylation | ISO | VAV2 (Homo sapiens) | 6480464 | aflatoxin B2 affects the methylation of VAV2 intron | CTD | PMID:30157460 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of VAV2 mRNA | CTD | PMID:30779732 | antirheumatic drug | decreases expression | ISO | VAV2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of VAV2 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | VAV2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of VAV2 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | VAV2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of VAV2 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | VAV2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of VAV2 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | VAV2 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to VAV2 mRNA] | CTD | PMID:32406909 | arsenous acid | decreases response to substance | ISO | VAV2 (Homo sapiens) | 6480464 | VAV2 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | benzo[a]pyrene | decreases expression | ISO | VAV2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of VAV2 mRNA | CTD | PMID:20064835 | benzo[a]pyrene | affects methylation | ISO | VAV2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of VAV2 intron | CTD | PMID:30157460 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | VAV2 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | benzo[e]pyrene | affects methylation | ISO | VAV2 (Homo sapiens) | 6480464 | benzo(e)pyrene affects the methylation of VAV2 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of VAV2 mRNA | CTD | PMID:25181051 more ... | bisphenol A | multiple interactions | ISO | VAV2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of VAV2 gene | CTD | PMID:31601247 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of VAV2 gene | CTD | PMID:28505145 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of VAV2 promoter | CTD | PMID:22457795 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of VAV2 mRNA | CTD | PMID:33453195 | caffeine | affects phosphorylation | ISO | VAV2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of VAV2 protein | CTD | PMID:35688186 | choline | multiple interactions | ISO | Vav2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VAV2 gene | CTD | PMID:20938992 | dexamethasone | increases expression | ISO | Vav2 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of VAV2 mRNA | CTD | PMID:22733784 | diarsenic trioxide | decreases response to substance | ISO | VAV2 (Homo sapiens) | 6480464 | VAV2 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | dibenziodolium | multiple interactions | ISO | Vav2 (Mus musculus) | 6480464 | diphenyleneiodonium inhibits the reaction [VAV2 protein affects the localization of CD38 protein] more ... | CTD | PMID:23940720 | doxorubicin | decreases expression | ISO | VAV2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of VAV2 mRNA | CTD | PMID:29803840 | fenthion | decreases expression | ISO | Vav2 (Mus musculus) | 6480464 | Fenthion results in decreased expression of VAV2 mRNA | CTD | PMID:34813904 | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of VAV2 mRNA | CTD | PMID:34044035 | folic acid | multiple interactions | ISO | Vav2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VAV2 gene | CTD | PMID:20938992 | FR900359 | increases phosphorylation | ISO | VAV2 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of VAV2 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | ISO | VAV2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of VAV2 gene | CTD | PMID:31601247 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of VAV2 mRNA | CTD | PMID:22061828 and PMID:33387578 | indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of VAV2 mRNA | CTD | PMID:22129741 | ivermectin | decreases expression | ISO | VAV2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of VAV2 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | Vav2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VAV2 gene | CTD | PMID:20938992 | lead(0) | affects splicing | ISO | VAV2 (Homo sapiens) | 6480464 | Lead affects the splicing of VAV2 mRNA | CTD | PMID:28903495 | lipopolysaccharide | multiple interactions | ISO | VAV2 (Homo sapiens) | 6480464 | [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of VAV2 mRNA | CTD | PMID:35877022 | methapyrilene | affects methylation | ISO | VAV2 (Homo sapiens) | 6480464 | Methapyrilene affects the methylation of VAV2 intron | CTD | PMID:30157460 | methidathion | decreases expression | ISO | Vav2 (Mus musculus) | 6480464 | methidathion results in decreased expression of VAV2 mRNA | CTD | PMID:34813904 | methotrexate | decreases expression | ISO | VAV2 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of VAV2 mRNA | CTD | PMID:17400583 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of VAV2 gene | CTD | PMID:35440735 | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of VAV2 gene | CTD | PMID:33148267 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of VAV2 mRNA | CTD | PMID:22129741 | nickel sulfate | decreases expression | ISO | VAV2 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of VAV2 mRNA | CTD | PMID:16780908 | nickel sulfate | increases expression | ISO | VAV2 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of VAV2 mRNA | CTD | PMID:16780908 | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of VAV2 mRNA | CTD | PMID:24136188 | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of VAV2 mRNA | CTD | PMID:23665939 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of VAV2 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | Vav2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of VAV2 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | VAV2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of VAV2 mRNA | CTD | PMID:26690555 | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in increased methylation of VAV2 gene | CTD | PMID:33148267 | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of VAV2 mRNA | CTD | PMID:19162173 | potassium chromate | multiple interactions | ISO | VAV2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VAV2 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | VAV2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of VAV2 mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of VAV2 mRNA | CTD | PMID:19162173 | quercetin | increases phosphorylation | ISO | VAV2 (Homo sapiens) | 6480464 | Quercetin results in increased phosphorylation of VAV2 protein | CTD | PMID:35688186 | selenic acid | decreases expression | ISO | Vav2 (Mus musculus) | 6480464 | Selenic Acid results in decreased expression of VAV2 mRNA | CTD | PMID:16444006 | sodium arsenite | increases expression | ISO | Vav2 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of VAV2 mRNA | CTD | PMID:22700541 | superoxide | multiple interactions | ISO | Vav2 (Mus musculus) | 6480464 | 2-acetylphenothiazine inhibits the reaction [VAV2 protein results in increased abundance of Superoxides] and diphenyleneiodonium inhibits the reaction [VAV2 protein results in increased abundance of Superoxides] | CTD | PMID:23940720 | superoxide | increases abundance | ISO | Vav2 (Mus musculus) | 6480464 | VAV2 protein results in increased abundance of Superoxides | CTD | PMID:23940720 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of VAV2 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VAV2 mRNA] | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of VAV2 mRNA | CTD | PMID:34492290 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of VAV2 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of VAV2 mRNA | CTD | PMID:25729387 | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of VAV2 gene | CTD | PMID:27618143 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of VAV2 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | VAV2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of VAV2 mRNA | CTD | PMID:28542535 | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of VAV2 mRNA | CTD | PMID:30589522 | Tubeimoside II | multiple interactions | ISO | VAV2 (Homo sapiens) | 6480464 | tubeimoside II inhibits the reaction [TGFB1 protein results in increased phosphorylation of VAV2 protein] | CTD | PMID:33412154 | tungsten | decreases expression | ISO | Vav2 (Mus musculus) | 6480464 | Tungsten results in decreased expression of VAV2 mRNA | CTD | PMID:30912803 | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of VAV2 mRNA | CTD | PMID:24136188 | valproic acid | increases expression | ISO | VAV2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of VAV2 mRNA | CTD | PMID:23179753 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of VAV2 mRNA | CTD | PMID:20566332 and PMID:23034163 | vinclozolin | decreases methylation | EXP | | 6480464 | vinclozolin results in decreased methylation of VAV2 gene | CTD | PMID:31079544 | |